All News

Pharmacy associations offered a range of comments after the Supreme Court ruling that upheld key elements of the Affordable Care Act

We've already felt the pain. When will we go for the gain? How many physical breakdowns, ruined home lives, and professional traumas is it gonna take before we finally say enough is enough and ORGANIZE?

In a competitive profession and an age of limits, the formula for success is still pretty simple: Sell yourself - and then deliver!

A round-up of OTC products to treat eye and ear problems

CMS is assessing genetic testing for the older population

Recent changes to Medicaid's reimbursement rules raise many confusing questions. Drug Topics' senior legal columnist sets out to clarify some key points

Adding pharmacists to the hospital discharge process is shown to have a positive effect on combating hospital readmission rates

Maybe the best way to change the environment in pharmacy is to have an old-fashioned '60s-style protest

FDA approves avanafil and tafluprost

A survey of new Rx, new generic, and new OTC products

Bacterial contaminants have been traced back to a robot in a Winston-Salem, N.C. health center pharmacy

It was a regulatory milestone, yet the expected leap forward for personalized medicine never happened. But all may not yet be lost

Readers share their rules for getting through the day, memories of technologies past, and a call to arms

Walgreens has appointed James Skinner as its new non-executive chairman of the board. Skinner has been a Walgreens board member since 2005 and recently retired as CEO of McDonalds.

FDA is alerting healthcare professionals to the possibility that a 32-mg single intravenous dose of ondansetron (Zofran, ondansetron hydrochloride, and generics) could lead to QT interval prolongation, putting patients at risk for a potentially fatal heart rhythm known as Torsades de Pointes.

FDA has approved the marketing of the first nucleic acid test that can identify in less than 3 hours 12 different bacterial types known to cause bloodstream infections.

Comorbidity from chronic diseases and severity of illness increased the likelihood of adverse drug reactions in senior patients, according to a new study published online June 26 in the Annals of Pharmacotherapy.

Annual global spending on medicines will reach nearly $1.2 trillion by 2016, while U.S. spending growth is projected to soar to between $350 and $380 billion by 2016, according to a new report.

FDA is ridding the market of single-ingredient oxycodone capsules that are being distributed without an FDA-approved application.

Diplomat Specialty Pharmacy has promoted Atheer Kaddis, PharmD, to senior vice president of sales and marketing.

Raleigh-based Kerr Drug has promoted Mark J. Gregory, RPh, to senior vice president of store operations.

FDA recently released the results of an analysis of a limited number of samples of hydroxyprogesterone caproate active pharmaceutical ingredients and compounded hydroxyprogesterone caproate, finding no major safety concerns.

Lupin has received FDA approval to market a generic version of Lyrica (Pfizer), but the company has not yet launched it, according to Firstword Pharma.

Patients treated with olmesartan may be at risk of a severe form of spruelike enteropathy, which improves when the drug is discontinued, according to a case series study published online June 25 in Mayo Clinic Proceedings.

Older women with acute pyelonephritis can be successfully and safely treated with oral ciprofloxacin for 7 days, according to a study published online June 21 in The Lancet.

Vitamin D plus calcium supplementation consistently reduced mortality among elderly patients compared with vitamin D supplementation alone, according to a study published online May 17 in the Journal of Clinical Endocrinology and Metabolism.

Brightly colored prescription warning labels applied by pharmacies fail to adequately capture the attention of older patients, suggesting that current labeling standards should be reconsidered to make them more effective, according to a study published online June 14 in PLoS ONE.

At their recent ideaShare event, McKesson highlighted its Sponsored Clinical Services Network for hundreds of independent retail pharmacy owners and community pharmacists who are focused on increasing their role in healthcare delivery, improving patient outcomes, and finding new reimbursement avenues, the company said in a release.